Oxaliplatin
Summary
Persistence. It cannot be excluded that oxaliplatin is persistent, due to lack of data.
Bioaccumulation. It cannot be excluded that oxaliplatin bioaccumulates, due to lack of data.
Toxicity. It cannot be excluded that oxaliplatin is toxic, due to lack of data.
Risk. Risk of environmental impact of oxaliplatin cannot be excluded, due to the lack of environmental toxicity data.
This summary information comes from fass.se.
Detailed information
Fass environmental information
Fass environmental information for Oxaliplatin Teva from Teva Sweden AB (retrieved on 2026-02-24).
Hazard
Persistence: No data.
Bioaccumulation: No data.
Toxicity: No data.
Risk
PEC is based on sales data in Sweden in year 2023.
PEC = 0.000521 microg/L.
PNEC = No data.
According to the EMA guideline on environmental risk assessment of medicinal products, the use of oxaliplatin is unlikely to pose an environmental risk, as the predicted environmental concentration (PEC) is below the action limit of 0.01 microg/L.
Risk of environmental impact of oxaliplatin (PEC/PNEC) cannot be excluded, due to the lack of environmental toxicity data.
References
Author: Health and Medical Care Administration, Region Stockholm